Calcium pyrophosphate dihydrate (CPPD) crystal deposition disease is a common form of arthritis, particularly in the elderly. Prevalence approaches 50 percent in those over 80. CPPD crystals cause acute attacks of gout-like arthritis, but more importantly are associated with debilitating degenerative arthritis. In vitro and in vivo data strongly suggest that these crystals cause or amplify cartilage degeneration. This proposal focuses on the source of inorganic pyrophosphate (PPi), the anion constituent of CPPD crystals. Disordered PPi metabolism is clearly implicated in CPPD crystal deposition. Specific emphasis will be placed on mechanisms underlying PPi generation in extracellular cartilage matrix where crystals form. The effector arm of extracellular PPi (ePPi) generation involves the ectoenzyme nucleoside triphosphate pyrophosphohydrolase (NTPPPH), which generates ePPi from extracellular nucleoside triphosphates such as ATP. NTPPPH activity is highly expressed in articular cartilage. The availability of extracellular ATP substrate for NTPPPH is rate-limiting for generation of ePPi and the most likely cellular source of that ATP is the chondrocyte. These studies are designed to determine the effects of factors that modulate ePPi formation upon the release of ATP from chondrocytes. Specific emphasis is placed on growth factors (transforming growth factor-beta and insulin-like growth factor-I), on chondrocyte donor age, on transduction pathways (protein kinase C and cAMP-related), and on purine receptors (P1and P2). All of the aforementioned influence ePPi elaboration by chondrocytes. The second goal of this proposal is to determine the mechanisms of ATP egress from chondrocytes. Specific focus will be on ATP binding cassette proteins (analogues of human ABC1 and p-glycoprotein expressed in chondrocytes), a gap junction protein (connexin 43), and ANK protein as possible transporters. The intent of these studies is to develop insights into the pathogenesis of CPPD deposition disease so that therapeutic options may be generated.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Project (R01)
Project #
2R01AR038656-14A2
Application #
6437961
Study Section
Orthopedics and Musculoskeletal Study Section (ORTH)
Program Officer
Tyree, Bernadette
Project Start
1987-05-01
Project End
2007-03-31
Budget Start
2002-04-19
Budget End
2003-03-31
Support Year
14
Fiscal Year
2002
Total Cost
$282,000
Indirect Cost
Name
Medical College of Wisconsin
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
073134603
City
Milwaukee
State
WI
Country
United States
Zip Code
53226
Uzuki, Miwa; Sawai, Takashi; Ryan, Lawrence M et al. (2014) Upregulation of ANK protein expression in joint tissue in calcium pyrophosphate dihydrate crystal deposition disease. J Rheumatol 41:65-74
Rosenthal, A K; Hempel, D; Kurup, I V et al. (2010) Purine receptors modulate chondrocyte extracellular inorganic pyrophosphate production. Osteoarthritis Cartilage 18:1496-501
Ryan, Lawrence M; Rosenthal, Ann K (2003) Metabolism of extracellular pyrophosphate. Curr Opin Rheumatol 15:311-4
Hirose, Jun; Ryan, Lawrence M; Masuda, Ikuko (2002) Up-regulated expression of cartilage intermediate-layer protein and ANK in articular hyaline cartilage from patients with calcium pyrophosphate dihydrate crystal deposition disease. Arthritis Rheum 46:3218-29
Derfus, Beth A; Kurian, Jason B; Butler, Jeffrey J et al. (2002) The high prevalence of pathologic calcium crystals in pre-operative knees. J Rheumatol 29:570-4
Derfus, B A; Camacho, N P; Olmez, U et al. (2001) Transforming growth factor beta-1 stimulates articular chondrocyte elaboration of matrix vesicles capable of greater calcium pyrophosphate precipitation. Osteoarthritis Cartilage 9:189-94
Le, M; Gohr, C M; Rosenthal, A K (2001) Transglutaminase participates in the incorporation of latent TGFbeta into the extracellular matrix of aging articular chondrocytes. Connect Tissue Res 42:245-53
Masuda, I; Iyama, K I; Halligan, B D et al. (2001) Variations in site and levels of expression of chondrocyte nucleotide pyrophosphohydrolase with aging. J Bone Miner Res 16:868-75
Rosenthal, A K; Masuda, I; Gohr, C M et al. (2001) The transglutaminase, Factor XIIIA, is present in articular chondrocytes. Osteoarthritis Cartilage 9:578-81
Rosenthal, A K; Gohr, C M; Henry, L A et al. (2000) Participation of transglutaminase in the activation of latent transforming growth factor beta1 in aging articular cartilage. Arthritis Rheum 43:1729-33

Showing the most recent 10 out of 42 publications